Steegen K, Levin L, Evans D, Technau KG, et al. Minimal Cross-resistance to Tenofovir in Children and Adolescents Failing ART Makes Them Eligible for Tenofovir-Lamivudine-Dolutegravir Treatment. Pediatr Infect Dis J 2022 Jul 20. pii: 00006454-990000000-00138.
PMID: 35895893